Price $50.71 |
Market Cap
7.7B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
38.2
|
P/B
80.09
|
P/S
13.38
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
34.0
|
Op. Cash Flow
240.2K
|
FCF
1.6
|
|
Op. Margin
42.50%
|
Net Margin
36.40%
|
ROE
99.70%
|
ROI
38.10%
|
|
ROA
14.30%
|
EPS Growth
-47.50%
|
Current Ratio
7.9
|
Debt/Equity
399.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.96 | - | - | 106.2M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $4.00 | - | - | 47.6M | Strong Buy |
| Statera Biopharma Inc (STAB) | $0.03 | - | - | 4.9M | Strong Buy |
| Precision Optics Corporation I (POCI) | $6.12 | - | - | 31.4M | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.25 | - | - | 443.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
